| 发明名称 |
Agranolocytosis screening procedure |
| 摘要 |
Certain patients undergoing clozapine drug therapy may be vulnerable to agranulocytosis. It has been found that agranulocytosis vulnerability is correlated with the presence of HLA antigens B38, DR4 and DQw3. Accordingly, a method is provided for detecting such patients, and an HLA kit is provided.
|
| 申请公布号 |
US5223399(A) |
申请公布日期 |
1993.06.29 |
| 申请号 |
US19910671587 |
申请日期 |
1991.03.19 |
| 申请人 |
LONG ISLAND JEWISH MEDICAL CENTER;DANA-FARBER CANCER INSTITUTE |
发明人 |
LIEBERMAN, JEFFREY A.;YUNIS, EDMOND J. |
| 分类号 |
G01N33/569 |
主分类号 |
G01N33/569 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
